The Hon. Fanny Law, GBS, JP, Chairperson of HKSTP remarks that Hong Kong is well-positioned to become an Asian hub for stem cell technology as well as the commercialisation of cell therapy. As the centrepiece of Hong Kong’s innovation ecosystem, HKSTP proactively reaches out and connects our technology talents with universities and research institutions, investors industries in China and around the world to foster the development of stem cell technologies.
Add Comment